Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 336 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

Role of metformin, Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) receptor agonists, and orlistat based multidrug therapy in glycemic control, weight loss, and euglycemia in diabesity: A real-world experience

Dutta Deep, Jaisani Ritu, Khandelwal Deepak, Ghosh Soumitra, Malhotra Rajiv, Kalra Sanjay

Year : 2019| Volume: 23| Issue : 4 | Page no: 460-467

   This article has been cited by
 
1 Targeting insulin resistance with selected antidiabetic agents prevents menopausal associated central obesity, dysglycemia, and cardiometabolic risk
Satish Jankie,Lexley Maureen Pinto Pereira
Post Reproductive Health. 2021; 27(1): 45
[Pubmed]  [Google Scholar] [DOI]
2 Sodium Glucose Co-Transporter 2 Inhibition Does Not Favorably Modify the Physiological Responses to Dietary Counselling in Diabetes-Free, Sedentary Overweight and Obese Adult Humans
Shane P.P. Ryan,Alissa A. Newman,Jessie R. Wilburn,Lauren D. Rhoades,S. Raj J. Trikha,Ellen C. Godwin,Hayden M. Schoenberg,Micah L. Battson,Taylor R. Ewell,Gary J. Luckasen,Laurie M. Biela,Christopher L. Melby,Christopher Bell
Nutrients. 2020; 12(2): 510
[Pubmed]  [Google Scholar] [DOI]

 

Read this article